Over 2.24 lakh beneficiaries given COVID-19 vaccine so far; 447 cases of adverse effect reported: Govt

2,07,229 received jabs on day one of the drive

Over 2.24 lakh beneficiaries given COVID-19 vaccine so far; 447 cases of adverse effect reported: Govt

A medic shows a Covishield vaccine vial, after the virtual launch of COVID-19 vaccination drive by Prime Minister Narendra Modi, at Government Girls School in Gurugram. PTI

New Delhi, January 17

A total of 2,24,301 beneficiaries have been inoculated with COVID-19 vaccine so far, out of which only 447 adverse events following immunisation (AEFI) were reported, the Union Health Ministry said on day two of the nationwide vaccination drive on Sunday.

Addressing a press briefing, the ministry’s Additional Secretary Manohar Agnani said out of the 447 adverse events following immunisation, only three required hospitalisation.

“Today being Sunday, only six states conducted vaccination drive and in 553 sessions a total of 17,072 beneficiaries were vaccinated,” he said.

The six states where the vaccination drive was carried out on Sunday are Andhra Pradesh, Arunachal Pradesh, Karnataka, Kerala, Manipur and Tamil Nadu, he added.

Agnani said a total of 2,24,301 beneficiaries have been vaccinated till January 17 as per provisional reports, adding that 2,07,229 of them received the jabs on day one of the drive.

“A total of 447 AEFI have been reported on January 16 and 17, out of which only three required hospitalisation. Most of the AEFI reported so far are minor like fever, headache, nausea,” he said.

He said a meeting was held with all states and union territories on Sunday to review the progress of the drive, identify bottlenecks and plan corrective actions.

Prime Minister Narendra Modi rolled out the world’s largest inoculation drive against COVID-19 on Saturday and said the two vaccines being deployed will ensure a “decisive victory” for India against the pandemic.

India has approved two vaccines—Covaxin developed by Bharat Biotech and Covishield from the Oxford/AstraZeneca stable being manufactured by the Serum Institute of India—for emergency use in the country.

According to the government, the shots will be offered first to an estimated one crore healthcare workers and around two crore frontline workers, and then to persons above 50 years of age, followed by persons younger than 50 years of age with associated comorbidities. PTI

Top Stories

Highest-ever single-day spike in India with 2.17 lakh fresh Covid cases

Highest-ever single-day spike in India with 2.17 lakh fresh Covid cases

The death toll increased to 1,74,308 with 1,185 new fataliti...

After meeting Badnore, IG Vijay Pratap hints he is firm on resigning, has convinced Capt

After meeting Badnore, IG Vijay Pratap hints he is firm on resigning, has convinced Capt

Said he was firm on his decision even though the CM had trie...

Bargari sacrilege cases: Navjot Sidhu wants SIT findings made public

Bargari sacrilege cases: Navjot Sidhu wants SIT findings made public

At Behbal Kalan, two people were killed in the police firing

Former CBI director Ranjit Sinha dies at 68

Former CBI director Ranjit Sinha dies at 68

It is understood that he was confirmed positive for coronavi...

Indian-origin man's body found floating in river in New York

Indian-origin man's body found floating in river in New York

Police sources say there were no immediate apparent signs of...

Cities

View All